Zogenix Inc. buy melinda
Start price
22.06.17
/
50%
€13.44
Target price
29.09.17
€30.00
Performance (%)
79.10%
End price
29.09.17
€24.07
Summary
This prediction ended on 29.09.17 with a price of €24.07. The BUY prediction by melinda for Zogenix Inc. saw massive gains of 79.10%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Zogenix Inc. | - | - | - | - |
| iShares Core DAX® | -2.195% | 0.670% | 0.546% | 51.111% |
| iShares Nasdaq 100 | -2.629% | 2.992% | 34.108% | 91.988% |
| iShares Nikkei 225® | -2.021% | 3.141% | 53.424% | 65.852% |
| iShares S&P 500 | -1.670% | 2.405% | 23.220% | 66.636% |
Comments by melinda for this prediction
In the thread Zogenix Inc. diskutieren
* Zogenix Inc. - 22. Juni erteilte die US FDA seine experimentelle Droge, die Ausweisung von Orphan - ZX008 Medikament für die Behandlung von Lennox-Gastaut - Syndrom
(Vom Mitglied beendet)